RE:RE:RE:Here's my best i-Dialco guessYeah, except Infomed doesn't mention Spectral or a a joint venture in their news release. They actually call i-Dialco their "subsidiary".
We paid for the FDA approvals of SAMI and DIMI. The approvals were in Spectral's name and were probably worth the 30%. A fight over them could have tied up any N American progress for years.
But as Spectral continues to deny that any material change even happened- these giant questions will just go unanswered..
Seems like a pretty fair deal for investors.